Cheryl,
Before I logged off yesterday, the FDA news came out and we have seen the wild trading, for just 50 min.s. I was disappointed because of the price action. I did not expect a rally, but I certainly did not expect to see LGND below 10 during the day. This morning, I'm looking more positively. After all, one should view the panel's recommendation as a validation of LGND's technology platform, rather than the approval of a drug targeting a narrowing population. (I'm not sure about this either. Wasn't somebody on the thread talking about new HIV strains developing, resistant to protease inhibitors and combination treatments ? Was it Henry ?).
However, I agree with your former posts; i.e. the developments on the large population indications will convince investors to jump on LGND and drive the price into uncharted territory.
One question. When doctors prescribe Panretin, is it paid for by the health insurers in U.S. or do patients have to pay from their own pockets ?
OFF TOPIC
<<Alper, what time is it in Turkey? >>
As I write this, it was 13:00. We are 7 hours ahead of EST, and 10 hours ahead of PST. However, I can check the thread quite often during the day. Better yet, I can daytrade for almost 5 hours, that is as long as my daughter allows me to.
Cheers
Alper |
